Login

NON-SUBSCRIBER OPTIONS
FREE TRIAL   |   NEWSSTAND

The Vitals

Gottlieb Condemns Pharma Exec’s Defense For Quadrupling Price Of Generic

September 12, 2018
FDA Commissioner Scott Gottlieb on Tuesday (Sept. 11) condemned the pharmaceutical executive who said in a Financial Times story that it was his “moral requirement” to quadruple the price of its a generic antibiotic drug nitrofurantoin to $2,392 a bottle. The publication interviewed Nirmal Mulye, CEO of Missouri-based Nostrum Laboratories , about the price increase. Mulye blamed supply shortages, and resulting price increases, on FDA’s new, stricter manufacturing rules. Gottlieb reiterated that FDA is promoting competition by speeding generic...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, news from FDA and much more.